{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T16:04:06Z","timestamp":1781712246204,"version":"3.54.5"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2019YFC0118401"],"award-info":[{"award-number":["2019YFC0118401"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2019YFC0118400"],"award-info":[{"award-number":["2019YFC0118400"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Eye Research"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.exer.2020.108069","type":"journal-article","created":{"date-parts":[[2020,5,18]],"date-time":"2020-05-18T21:26:09Z","timestamp":1589837169000},"page":"108069","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"special_numbering":"C","title":["The prognostic landscape of adaptive immune resistance signatures and infiltrating immune cells in the tumor microenvironment of uveal melanoma"],"prefix":"10.1016","volume":"196","author":[{"given":"Yijie","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yufeng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xizhe","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiling","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Shan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.exer.2020.108069_bib1","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s10555-017-9663-3","article-title":"The biology of uveal melanoma","volume":"36","author":"Amaro","year":"2017","journal-title":"Canc. Metastasis Rev."},{"key":"10.1016\/j.exer.2020.108069_bib2","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.immuni.2016.05.001","article-title":"Lag-3, tim-3, and TIGIT: Co-inhibitory receptors with specialized functions in immune regulation","volume":"44","author":"Anderson","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.exer.2020.108069_bib3","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1186\/s13059-017-1349-1","article-title":"xCell: digitally portraying the tissue cellular heterogeneity landscape","volume":"18","author":"Aran","year":"2017","journal-title":"Genome Biol."},{"key":"10.1016\/j.exer.2020.108069_bib4","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1158\/1078-0432.CCR-13-2690","article-title":"Human melanoma metastases demonstrate nonstochastic site-specific antigen heterogeneity that correlates with T-cell infiltration","volume":"20","author":"Bartlett","year":"2014","journal-title":"Clin. Canc. Res."},{"key":"10.1016\/j.exer.2020.108069_bib5","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/nm.2328","article-title":"Why don't we get more cancer? A proposed role of the microenvironment in restraining cancer progression","volume":"17","author":"Bissell","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.exer.2020.108069_bib6","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1159\/000334576","article-title":"Uveal melanoma: the inflammatory microenvironment","volume":"4","author":"Bronkhorst","year":"2012","journal-title":"J. Innate Immun."},{"key":"10.1016\/j.exer.2020.108069_bib7","doi-asserted-by":"crossref","first-page":"5370","DOI":"10.1167\/iovs.11-9280","article-title":"Different subsets of tumor-infiltrating lymphocytes correlate with macrophage influx and monosomy 3 in uveal melanoma","volume":"53","author":"Bronkhorst","year":"2012","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2020.108069_bib8","doi-asserted-by":"crossref","first-page":"979","DOI":"10.3390\/cancers11070979","article-title":"Tumour angiogenesis in uveal melanoma is related to genetic evolution","volume":"11","author":"Brouwer","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.exer.2020.108069_bib9","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1038\/eye.2012.126","article-title":"Progress in the management of patients with uveal melanoma. The 2012 Ashton Lecture","volume":"26","author":"Damato","year":"2012","journal-title":"Eye"},{"key":"10.1016\/j.exer.2020.108069_bib10","first-page":"112","article-title":"Lymphocytic infiltration in uveal malignant melanoma","volume":"65","author":"De La Cruz","year":"1990","journal-title":"Canc. Am. Canc. Soc."},{"key":"10.1016\/j.exer.2020.108069_bib11","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1158\/1541-7786.MCR-18-0114","article-title":"Digital PCR-based T-cell quantification\u2013assisted deconvolution of the microenvironment reveals that activated macrophages drive tumor inflammation in uveal melanoma","volume":"16","author":"de Lange","year":"2018","journal-title":"Mol. Canc. Res."},{"key":"10.1016\/j.exer.2020.108069_bib12","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/cjp2.86","article-title":"Patterns of BAP1 protein expression provide insights into prognostic significance and the biology of uveal melanoma","volume":"4","author":"Farquhar","year":"2018","journal-title":"J. Pathol. Clin. Res."},{"key":"10.1016\/j.exer.2020.108069_bib13","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1002\/path.5384","article-title":"Loss of BAP1 expression is associated with an immunosuppressive microenvironment in uveal melanoma, with implications for immunotherapy development","volume":"250","author":"Figueiredo","year":"2020","journal-title":"J. Pathol."},{"key":"10.1016\/j.exer.2020.108069_bib14","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1158\/2159-8290.CD-13-0330","article-title":"SF3B1 mutations are associated with alternative splicing in uveal melanoma","volume":"3","author":"Furney","year":"2013","journal-title":"Canc. Discov."},{"key":"10.1016\/j.exer.2020.108069_bib15","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1038\/ni.2703","article-title":"Innate and adaptive immune cells in the tumor microenvironment","volume":"14","author":"Gajewski","year":"2013","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.exer.2020.108069_bib16","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.celrep.2017.04.031","article-title":"Interferon receptor signaling pathways regulating PD-L1 and PD-L2 expression","volume":"19","author":"Garcia-Diaz","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.exer.2020.108069_bib17","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1007\/s00262-017-1991-1","article-title":"Genetic evolution of uveal melanoma guides the development of an inflammatory microenvironment","volume":"66","author":"Gezgin","year":"2017","journal-title":"Canc. Immunol. Immunother."},{"key":"10.1016\/j.exer.2020.108069_bib18","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ccr.2012.02.022","article-title":"Accessories to the crime: functions of cells recruited to the tumor microenvironment","volume":"21","author":"Hanahan","year":"2012","journal-title":"Canc. Cell"},{"key":"10.1016\/j.exer.2020.108069_bib19","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ctrv.2017.08.009","article-title":"Immune checkpoint blockade for unresectable or metastatic uveal melanoma: a systematic review","volume":"60","author":"Heppt","year":"2017","journal-title":"Canc. Treat Rev."},{"key":"10.1016\/j.exer.2020.108069_bib20","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/nature14011","article-title":"Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients","volume":"515","author":"Herbst","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.exer.2020.108069_bib21","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/j.ophtha.2018.03.011","article-title":"The cancer Genome Atlas project: an integrated molecular view of uveal melanoma","volume":"125","author":"Jager","year":"2018","journal-title":"Ophthalmology"},{"key":"10.1016\/j.exer.2020.108069_bib22","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1038\/bjc.2014.417","article-title":"Lack of BAP1 protein expression in uveal melanoma is associated with increased metastatic risk and has utility in routine prognostic testing","volume":"111","author":"Kalirai","year":"2014","journal-title":"Br. J. Canc."},{"key":"10.1016\/j.exer.2020.108069_bib23","doi-asserted-by":"crossref","first-page":"4651","DOI":"10.1167\/iovs.03-0538","article-title":"Very long-term prognosis of patients with malignant uveal melanoma","volume":"44","author":"Kujala","year":"2003","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2020.108069_bib24","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1634\/theoncologist.2015-0522","article-title":"Prognosis of mucosal, uveal, acral, nonacral cutaneous, and unknown primary melanoma from the time of first metastasis","volume":"21","author":"Kuk","year":"2016","journal-title":"Oncol."},{"key":"10.1016\/j.exer.2020.108069_bib25","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s13059-016-1028-7","article-title":"Comprehensive analyses of tumor immunity: implications for cancer immunotherapy","volume":"17","author":"Li","year":"2016","journal-title":"Genome Biol."},{"key":"10.1016\/j.exer.2020.108069_bib26","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1167\/iovs.07-0786","article-title":"Monosomy of chromosome 3 and an inflammatory phenotype occur together in uveal melanoma","volume":"49","author":"Maat","year":"2008","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2020.108069_bib27","doi-asserted-by":"crossref","first-page":"303","DOI":"10.3389\/fimmu.2012.00303","article-title":"Influence of CD8+ T regulatory cells on intraocular tumor development","volume":"3","author":"McKenna","year":"2012","journal-title":"Front. Immunol."},{"key":"10.1016\/j.exer.2020.108069_bib28","doi-asserted-by":"crossref","first-page":"148","DOI":"10.3389\/fimmu.2012.00148","article-title":"Ocular immune privilege and ocular melanoma: parallel universes or immunological plagiarism?","volume":"3","author":"Niederkorn","year":"2012","journal-title":"Front. Immunol."},{"key":"10.1016\/j.exer.2020.108069_bib29","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1101\/gad.296962.117","article-title":"Focus on cutaneous and uveal melanoma specificities","volume":"31","author":"Pandiani","year":"2017","journal-title":"Gene Dev."},{"key":"10.1016\/j.exer.2020.108069_bib30","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1038\/nm.3394","article-title":"Microenvironmental regulation of tumor progression and metastasis","volume":"19","author":"Quail","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.exer.2020.108069_bib31","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.26476","article-title":"Simultaneous enumeration of cancer and immune cell types from bulk tumor gene expression data","volume":"6","author":"Racle","year":"2017","journal-title":"Elife"},{"key":"10.1016\/j.exer.2020.108069_bib32","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1158\/2159-8290.CD-15-0563","article-title":"Adaptive immune resistance: how cancer protects from immune attack","volume":"5","author":"Ribas","year":"2015","journal-title":"Canc. Discov."},{"key":"10.1016\/j.exer.2020.108069_bib33","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1093\/nar\/gkv007","article-title":"Limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.exer.2020.108069_bib34","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.ccell.2017.07.003","article-title":"Integrative analysis identifies four molecular and clinical subsets in uveal melanoma","volume":"32","author":"Robertson","year":"2017","journal-title":"Canc. Cell"},{"key":"10.1016\/j.exer.2020.108069_bib35","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1158\/1078-0432.CCR-15-2294","article-title":"Identification of an immunogenic subset of metastatic uveal melanoma","volume":"22","author":"Rothermel","year":"2016","journal-title":"Clin. Canc. Res."},{"key":"10.1016\/j.exer.2020.108069_bib36","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.3390\/cancers11081102","article-title":"Loss of BAP1 is associated with upregulation of the NFkB pathway and increased HLA class I expression in uveal melanoma","volume":"11","author":"Souri","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.exer.2020.108069_bib37","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.ccell.2015.03.001","article-title":"Immune checkpoint blockade: a common denominator approach to cancer therapy","volume":"27","author":"Topalian","year":"2015","journal-title":"Canc. Cell"},{"key":"10.1016\/j.exer.2020.108069_bib38","article-title":"Molecular profiling of primary uveal melanomas with tumor-infiltrating lymphocytes","volume":"8","author":"Triozzi","year":"2014","journal-title":"OncoImmunology"},{"key":"10.1016\/j.exer.2020.108069_bib39","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/nature13954","article-title":"PD-1 blockade induces responses by inhibiting adaptive immune resistance","volume":"515","author":"Tumeh","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.exer.2020.108069_bib40","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1016\/j.ophtha.2019.04.027","article-title":"Genetic analysis of uveal melanoma in 658 patients using the cancer Genome Atlas classification of uveal melanoma as A, B, C, and D","volume":"126","author":"Vichitvejpaisal","year":"2019","journal-title":"Ophthalmology"},{"key":"10.1016\/j.exer.2020.108069_bib41","first-page":"2603","article-title":"Immunohistochemistry of infiltrating lymphocytes in uveal malignant melanoma","volume":"34","author":"Whelchel","year":"1993","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2020.108069_bib42","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1056\/NEJMc1713444","article-title":"Tumor mutational burden and response rate to PD-1 inhibition","volume":"377","author":"Yarchoan","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.exer.2020.108069_bib43","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/j.ophtha.2016.01.023","article-title":"Uveal melanomas with SF3B1 mutations","volume":"123","author":"Yavuzyigitoglu","year":"2016","journal-title":"Ophthalmology"},{"key":"10.1016\/j.exer.2020.108069_bib44","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1038\/ncomms3612","article-title":"Inferring tumour purity and stromal and immune cell admixture from expression data","volume":"4","author":"Yoshihara","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.exer.2020.108069_bib45","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1089\/omi.2011.0118","article-title":"clusterProfiler: an R Package for comparing biological themes among gene clusters","volume":"16","author":"Yu","year":"2012","journal-title":"OMICS A J. Integr. Biol."}],"container-title":["Experimental Eye Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483520303286?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483520303286?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T05:06:38Z","timestamp":1757999198000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014483520303286"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":45,"alternative-id":["S0014483520303286"],"URL":"https:\/\/doi.org\/10.1016\/j.exer.2020.108069","relation":{},"ISSN":["0014-4835"],"issn-type":[{"value":"0014-4835","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The prognostic landscape of adaptive immune resistance signatures and infiltrating immune cells in the tumor microenvironment of uveal melanoma","name":"articletitle","label":"Article Title"},{"value":"Experimental Eye Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exer.2020.108069","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108069"}}